DKK1 Induced by 1,25D3 Is Required for the Mineralization of Osteoblasts.
Level 5 - mechanism / opinion, no new human data
In vitro laboratory study evaluating cellular and molecular mechanisms without human clinical data.
PubMed 31963554 · doi:10.3390/cells9010236
What was done
Investigated the molecular mechanism by which 1α,25-dihydroxyvitamin D3 (1,25D3) regulates Dickkopf-related protein 1 (DKK1) during osteoblast differentiation. The authors evaluated mRNA and protein levels of CCAAT/enhancer binding protein beta (C/EBPβ) and DKK1, direct binding of C/EBPβ to the human DKK1 promoter, the effects of C/EBPβ knockdown and overexpression, and the functional impact of blocking DKK1 on calcified nodule formation, alkaline phosphatase (ALP) activity, and collagen synthesis.
What was found
1,25D3 promoted C/EBPβ and DKK1 mRNA and protein expression at day 7 of osteoblast differentiation and induced direct binding of C/EBPβ to the human DKK1 promoter. Knockdown of C/EBPβ downregulated DKK1 expression (partially reversed by 1,25D3), whereas overexpression of C/EBPβ upregulated DKK1. 1,25D3 induced endoplasmic reticulum-to-extracellular secretion of DKK1. Neutralizing/blocking DKK1 attenuated calcified nodule formation in mineralized osteoblasts without affecting ALP activity or collagen synthesis. No exact numerical values or statistics were reported in the abstract.
Why it matters
It outlines a transcriptional mechanism linking active vitamin D3 to C/EBPβ-mediated DKK1 upregulation and identifies a requirement for DKK1 in osteoblast matrix mineralization.
Limits
The findings are derived solely from in vitro cell models and lack in vivo animal or human clinical verification. The abstract omits sample sizes, replicate counts, quantitative measurements, and effect sizes. The broader systemic effects of DKK1 on bone turnover were not investigated.
Cited by
- supports Vitamin D binding to osteoblasts stimulates bone formation.